EP02C-138 DPC4, P53 AND MTAP EXPRESSION IN PATIENTS WITH LOCALLY ADVANCED AND METASTASTIC PANCREATIC CANCER M. Walma 1 , L. Deguerre 1 , H. van Santvoort 1,2 , J. Offerhaus 3 , Q. Molenaar 1 and L. Brosens 3 1 Surgery, University Medical Center Utrecht, 2 Surgery, St. Antonius Ziekenhuis Nieuwegein, and 3 Pathology, University Medical Center Utrecht, Netherlands Introduction: Whole-genome sequencing studies have given extensive insight in the genetic landscape of resectable pancreatic cancer. However, little is known about the molecular features of locally advanced (LAPC) and metastatic pancreatic cancer. This study aims to describe the incidences of DPC4, P53 and MTAP mutations in advanced pancreatic cancer. Methods: Patients diagnosed with LAPC or metastastic pancreatic cancer between January 2007 and July 2016 were identified. All patients with available biopsy material and a tumorload above 10% were included. Immunohistochemical staining was performed using DPC4, P53 and MTAP antibodies. Loss of expression, wild type or overexpression were scored by an experienced pathologist and a second pathologist was consulted in case of doubt. Differences between LAPC and metastatic tumors were tested with the chi-square test. Results: A total of 63 patients were included, 42 (67%) with LAPC and 21 (33%) with metastatic pancreatic cancer. Forty samples (64%) showed loss of DPC4 expression and 49 (78%) a P53 mutation: loss of expression in 16 cases (25%) and overexpression in 33 cases (52%). MTAP loss was seen in 20 tumors (32%). Except for a trend in DPC4, no differences in frequencies were seen between LAPC and metastatic pancreatic cancer. DPC4 loss was seen in 30 LAPC patients (71%) versus 10 metastatic patients (48%)(p = 0.064). Conclusion: Locally advanced and metastatic pancreatic cancer do not differ in DPC4, P53 and MTAP expression. The loss in expression described in this study correspond to those in resectable pancreatic cancer described in literature. Introduction: This study aimed to evaluate clinicopathologic outcome of WHO grade 2 and 3 Pancreas NET and clarify the risk factor for survival and recurrence of WHO grade 2 and 3 pancreas NET. Methods: We retrospectively reviewed database of 126patients who underwent curtive intent surgery for pancreas NET at a single institute from January 2000 through december 2016. WHO grade 2(n = 29) and grade 3(n = 30) patients were included in this study. Clinicopathologic characteristics and overal survival, disease free survival rates were analyzed. Results: There were no significant difference in clinical characteristics between WHO grade 2 and 3 groups except age(p = 0.023). There was no significant difference in overall survival(p = 0.078), but there was significant difference in disease free survival(p = 0.012). Tumor location was the prognostic factor for overall survival in multivariate analysis(P=0.022). Poorly differentiation(P < 0.001), Positive resection margin(P = 0.007), Metastasis(P < 0.001) were risk factor for recurrence. Conclusions: Tumor location, differentiation, resection margin, metastasis are better prognostic factor than WHO grade for grade 2,3 Pancreas NET.
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EP02C-140 WHIPPLE'S PROCEDURE: A REVIEW OF A 5-YEAR CLINICAL EXPERIENCE AT A TERTIARY CARE CENTER
K. Sutariya and M. Vikani Cigis Gastrosurgery Centre, India Background: Pancreaticoduodenectomy seems to be the only way in resolving resectable periampullary tumors. This article is a case series with respect to the 5-year experience of the Whipple's procedure at CIGIS gastrosurgery center, Rajkot, India. Methods: Patient surgery details were gathered from the surgical records of the hospital. Data was analyzed and results were derived. Results: From 2012 till 2017, 105 whipple's surgery were performed. Mean age of cases was 55 years, mean hospital stay length was 9 days and mean operation time was 360 minutes. Most common presenting symptom was jaundice (80 %). Feeding jejunostomy was done in all patients and hence no patients suffered delayed gastric emptying. Rate of pancreatic fistula was 15%. Five patients developed post-operative bleeding for which angioembolisation had to be done. Three patients developed post-operative intra-abdominal collection for which drainage of collection was done. One patient had to be re-operated because of intestinal obstruction secondary to kink of FJ tube. There was mortality in one patient due to pulmonary embolism. Conclusions: It is true that hospital setting, socioeconomic level of the patients including their compliance, and the expertise of the surgical team can have an influence on the result of this operation, but it is not mandatory that this surgery can only be done at a high volume centre. If the operating surgeons are well trained in a high volume centre under a good surgeon, the procedure can be carried out safely and similar results can be reproduced even at a tertiary care centre.
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